Quality of life before autologous stem cells transplantation as prognostic factor in patients with malignant lymphomas

Currently high-doses chemotherapy (HD-PCT) + autologous hematopoietic stem cells transplantation (auto-HSCT) is the treatment ofchoice in patients with recurrent and progressive lymphomas. Most of quality of life (QoL) studies in lymphomas patients received HSCT limited on parameters dynamics assess...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu. L. Shevchenko, D. A. Fedorenko, V. Ya. Melnichenko, N. Ye. Mochkin, T. I. Ionova, A. A. Novik
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Онкогематология
Subjects:
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/7
Tags: Add Tag
No Tags, Be the first to tag this record!